Table 6 Comparison of the change in continuity of IS/OS segment after anti-VEGF treatment compared with pretherapy changes in the two groups.
Changes in IS/OS segment | Low ratio group (n = 30) | High ratio group (n = 31) | χ2 | P4 |
|---|---|---|---|---|
One months after treatment, n (%) | 1.723 | 0.436 | ||
Deterioration | 3a (10.0) | 1a (3.2) | ||
Stability | 23a (76.7) | 23a (74.2) | ||
Improvement | 4a (13.3) | 7a (22.6) | ||
Three months after treatment, n (%) | 1.462 | 0.509 | ||
Deterioration | 5a (26.7) | 3a (16.1) | ||
Stability | 22a (66.7) | 22a (41.9) | ||
Improvement | 3a (6.7) | 6a (41.9) |
